Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity

The development of an effective vaccine against HIV-1 has proven to be challenging. Broadly neutralizing antibodies (bNAbs), whilst exhibiting neutralization breadth and potency, are elicited only in a small subset of infected individuals and have yet to be induced by vaccination. Case-control studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayr, Luzia M., Decoville, Thomas, Schmidt, Sylvie, Laumond, Géraldine, Klingler, Jéromine, Ducloy, Camille, Bahram, Seiamak, Zolla-Pazner, Susan, Moog, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627290/
https://www.ncbi.nlm.nih.gov/pubmed/28978939
http://dx.doi.org/10.1038/s41598-017-12883-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627290/
https://www.ncbi.nlm.nih.gov/pubmed/28978939
http://dx.doi.org/10.1038/s41598-017-12883-6

Ejemplares similares